Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period:
Insider Trading Transactions for Aquestive Therapeutics Inc.
Goto 0, 1, 2, 3, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-02-09
Sale
2021-02-10
8:17 pm
Aquestive Therapeutics Inc. AQST Schobel Alexander Mark
Chief Innovation/Tech Officer
35,000 $6.75 $236,250 837,000
(Direct)
View
2021-02-08
Sale
2021-02-09
4:00 pm
Aquestive Therapeutics Inc. AQST Schobel Alexander Mark
Chief Innovation/Tech Officer
40,792 $6.5 $265,148 872,000
(Direct)
View
2020-08-18
Sale
2020-08-19
08:55 am
Aquestive Therapeutics Inc. AQST Maxwell John T.
CFO
3,000 $8 $24,000 150,614
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-03-10
Option Award
2022-03-14
11:26 am
N/A
2032-03-10
Aquestive Therapeutics Inc. AQST Barber Daniel
SVP-Chief Operating Officer
225,000 $0 225,000
(Direct)
View
2022-03-10
Option Award
2022-03-14
11:26 am
N/A
2032-03-10
Aquestive Therapeutics Inc. AQST Wood Theresa
VP
70,000 $0 70,000
(Direct)
View
2022-03-10
Option Award
2022-03-14
11:26 am
N/A
2032-03-10
Aquestive Therapeutics Inc. AQST TOTH A ERNEST JR
CFO
70,000 $0 70,000
(Direct)
View
2022-03-10
Option Award
2022-03-14
11:25 am
N/A
2032-03-10
Aquestive Therapeutics Inc. AQST Schobel Alexander Mark
Chief Innovation/Tech Officer
75,000 $0 75,000
(Direct)
View
2022-03-10
Option Award
2022-03-14
11:25 am
N/A
2032-03-10
Aquestive Therapeutics Inc. AQST Marshall Ken W.
SVP Chief Commercial Officer
80,000 $0 80,000
(Direct)
View
2022-03-10
Option Award
2022-03-14
11:25 am
N/A
2032-03-10
Aquestive Therapeutics Inc. AQST BRAENDER LORI J
VP
160,000 $0 160,000
(Direct)
View
2022-03-10
Option Award
2022-03-14
11:24 am
N/A
2032-03-10
Aquestive Therapeutics Inc. AQST Boyd Peter E.
VP
70,000 $0 70,000
(Direct)
View
2022-03-10
Option Award
2022-03-14
11:24 am
N/A
2032-03-10
Aquestive Therapeutics Inc. AQST Kendall Keith J
CEO
375,000 $0 375,000
(Direct)
View
2021-08-26
Gift
2021-08-27
1:39 pm
N/A
N/A
Aquestive Therapeutics Inc. AQST Kendall Keith J
CEO
1,000 $0 637,149
(Direct)
View
2021-06-15
Option Award
2021-06-21
4:05 pm
2022-06-15
2031-06-15
Aquestive Therapeutics Inc. AQST BROWN GREGORY B
Director
20,000 $0 95,085
(Direct)
View
2021-06-15
Option Award
2021-06-17
6:51 pm
2022-06-15
2031-06-15
Aquestive Therapeutics Inc. AQST Taglietti Marco
Director
20,000 $0 20,000
(Direct)
View
2021-06-15
Option Award
2021-06-17
6:51 pm
2022-06-15
2031-06-15
Aquestive Therapeutics Inc. AQST Cochran John
Director
20,000 $0 119,486
(Direct)
View
2021-06-15
Option Award
2021-06-17
6:51 pm
N/A
2031-06-15
Aquestive Therapeutics Inc. AQST TOTH A ERNEST JR
CFO
120,000 $0 120,000
(Direct)
View
2021-06-15
Option Award
2021-06-17
6:51 pm
2022-06-15
2031-06-15
Aquestive Therapeutics Inc. AQST Lurker Nancy
Director
20,000 $0 20,000
(Direct)
View
2021-06-15
Option Award
2021-06-17
6:51 pm
2022-06-15
2031-06-15
Aquestive Therapeutics Inc. AQST Scibetta James S
Director
20,000 $0 51,635
(Direct)
View
2021-06-15
Option Award
2021-06-17
6:50 pm
2022-06-15
2031-06-15
Aquestive Therapeutics Inc. AQST Krop Julie
Director
20,000 $0 20,000
(Direct)
View
2021-06-15
Option Award
2021-06-17
6:50 pm
2022-06-15
2031-06-15
Aquestive Therapeutics Inc. AQST COSTA SANTO J
Director
20,000 $0 37,327
(Direct)
View
2021-05-10
Gift
2021-06-01
4:11 pm
N/A
N/A
Aquestive Therapeutics Inc. AQST Cochran John
Director
37,500 $0 99,486
(Direct)
View
2021-03-12
Gift
2021-03-16
8:20 pm
N/A
N/A
Aquestive Therapeutics Inc. AQST BRATTON DOUGLAS K
MonoLine Partners L.P.
MonoLine RX L.P.
MonoLine RX II L.P.
MonoLine RX III L.P.
MonoSol Rx Genpar L.P.
MRX Partners LLC
Bratton Capital Inc.
Bratton Capital Management L.P.
10% Owner
62,500 $0 7,220,655
(Direct)
View
2021-03-12
Other
2021-03-16
8:20 pm
N/A
N/A
Aquestive Therapeutics Inc. AQST BRATTON DOUGLAS K
MonoLine Partners L.P.
MonoLine RX L.P.
MonoLine RX II L.P.
MonoLine RX III L.P.
MonoSol Rx Genpar L.P.
MRX Partners LLC
Bratton Capital Inc.
Bratton Capital Management L.P.
10% Owner
5,259,492 $0 7,220,655
(Indirect)
View
2021-03-12
Other
2021-03-16
8:20 pm
N/A
N/A
Aquestive Therapeutics Inc. AQST Cochran John
Director
61,901 $0 198,887
(Direct)
View
2021-03-11
Option Award
2021-03-15
5:10 pm
N/A
2031-03-11
Aquestive Therapeutics Inc. AQST Krop Julie
Director
28,500 $0 28,500
(Direct)
View
2021-03-11
Option Award
2021-03-15
5:10 pm
N/A
2031-03-11
Aquestive Therapeutics Inc. AQST TOTH A ERNEST JR
CFO
2,500 $0 2,500
(Direct)
View
2021-03-11
Option Award
2021-03-15
5:10 pm
N/A
2031-03-11
Aquestive Therapeutics Inc. AQST Wood Theresa
VP
27,000 $0 27,000
(Direct)
View
2021-03-11
Option Award
2021-03-15
5:10 pm
N/A
2031-03-11
Aquestive Therapeutics Inc. AQST Kendall Keith J
CEO
250,000 $0 250,000
(Direct)
View
2021-03-11
Option Award
2021-03-15
5:10 pm
N/A
2031-03-11
Aquestive Therapeutics Inc. AQST Marshall Ken W.
SVP Chief Commercial Officer
40,000 $0 40,000
(Direct)
View
2021-03-11
Option Award
2021-03-15
5:10 pm
N/A
2031-03-11
Aquestive Therapeutics Inc. AQST Taglietti Marco
Director
28,500 $0 28,500
(Direct)
View
2021-03-11
Option Award
2021-03-15
5:10 pm
N/A
2031-03-11
Aquestive Therapeutics Inc. AQST BRAENDER LORI J
VP
75,000 $0 75,000
(Direct)
View
2021-03-11
Option Award
2021-03-15
5:10 pm
N/A
2031-03-11
Aquestive Therapeutics Inc. AQST Schobel Alexander Mark
Chief Innovation/Tech Officer
70,000 $0 70,000
(Direct)
View
2021-03-11
Option Award
2021-03-15
5:10 pm
N/A
2031-03-11
Aquestive Therapeutics Inc. AQST Barber Daniel
SVP-Chief Operating Officer
100,000 $0 100,000
(Direct)
View
2021-03-11
Option Award
2021-03-15
5:10 pm
N/A
2031-03-11
Aquestive Therapeutics Inc. AQST Boyd Peter E.
VP
35,000 $0 35,000
(Direct)
View
2020-12-30
Gift
2021-01-04
4:05 pm
N/A
N/A
Aquestive Therapeutics Inc. AQST Kendall Keith J
CEO
1,000 $0 638,149
(Direct)
View
2020-06-30
Tax Withholding
2020-07-02
4:00 pm
N/A
N/A
Aquestive Therapeutics Inc. AQST Schobel Alexander Mark
Chief Innovation/Tech Officer
94 $4.86 912,792
(Direct)
View
2020-06-30
Exercise
2020-07-02
4:00 pm
2020-06-30
N/A
Aquestive Therapeutics Inc. AQST Schobel Alexander Mark
Chief Innovation/Tech Officer
333 $0 912,792
(Direct)
View
2020-06-30
Tax Withholding
2020-07-02
4:00 pm
N/A
N/A
Aquestive Therapeutics Inc. AQST Kendall Keith J
CEO
148 $4.86 639,149
(Direct)
View
2020-06-30
Exercise
2020-07-02
4:00 pm
2020-06-30
N/A
Aquestive Therapeutics Inc. AQST Kendall Keith J
CEO
333 $0 639,149
(Direct)
View
2020-06-16
Option Award
2020-06-18
5:12 pm
2021-06-16
2030-06-16
Aquestive Therapeutics Inc. AQST BROWN GREGORY B
Director
14,000 $0 89,085
(Direct)
View
Goto 0, 1, 2, 3, Next